GSK receives further data from phase lll studies of albiglutide in type 2 diabetes
3 April 2012 | By GlaxoSmithKline
Data from seven studies support progression towards regulatory filings...
List view / Grid view
News
Interview with Robert Mattes, Applications Scientist, FOSS NIRSystems
2 April 2012 | By FOSS NIRSystems
Freddy White, European Pharmaceutical Review speaks to Robert Mattes, Applications Scientist, FOSS NIRSystems...
Gerresheimer grows in the emerging markets and acquires Indian pharma glass manufacturer Neutral Glass
2 April 2012 | By Gerresheimer AG
Gerresheimer AG, is committed to growth in the emerging markets...
Teva announces launch of generic Avapro® and generic Avalide® in the United States
2 April 2012 | By Teva Pharmaceutical Industries Ltd
180-day period of marketing exclusivity awarded...
Novartis QVA149 Phase III COPD studies meet primary endpoints
2 April 2012 | By Novartis
QVA149 efficacy, safety and exercise endurance primary endpoints all met[1],[2],[3]...
Shionogi-ViiV Healthcare announces initial data from pivotal phase III study of dolutegravir in HIV
2 April 2012 | By GlaxoSmithKline
SPRING-2 study meets primary endpoint of non-inferiority of dolutegravir...
Efficacy and safety data for ZOSTAVAX®
2 April 2012 | By Merck
Merck announced that data from the pivotal Phase III study with ZOSTAVAX® in adults ages 50 to 59 were published in the April 1 issue of Clinical Infectious Diseases...
Amgen and AstraZeneca announce collaboration
2 April 2012 | By Amgen
Collaboration comprises five monoclonal antibodies brodalumab (AMG 827) Phase 3 trial planned in 2012...
Merial acquires Newport Laboratories
2 April 2012 | By Merial
Merial, the Animal Health division of Sanofi, announced that it has acquired Newport Laboratories...
Lilly targets faulty c-MET receptor in cancer research studies presented at AACR Meeting
2 April 2012 | By Eli Lilly and Company
Studies provided basis for ongoing Phase I, II studies in gastric, other cancers...
A panel discussion with Catalent and industry experts
30 March 2012 | By Catalent Pharma Solutions
Cornell Stamoran, Catalent Pharma Solutions will be a guest panelist at New Jersey’s PharmFest 2012...
New pharmaceutical filling area for the facility in Pfreimd
30 March 2012 | By Gerresheimer AG
Gerresheimer Medical Plastic Systems continues to expand its range of services in order to meet customer demand...
Roche’s trastuzumab emtansine (T-DM1) showed positive Phase III results in HER2-positive metastatic breast cancer
30 March 2012 | By Roche
Roche have announced topline results of EMILIA...
Abbott’s PLEX-ID Molecular system and tests for broad microbial identification obtain CE Marking
30 March 2012 | By Abbott
New PLEX-ID system and three clinical tests introduced in the European Union...
New incentive plans in the Lundbeck Group
29 March 2012 | By H. Lundbeck A/S
The Board of Directors of H. Lundbeck A/S has resolved, pursuant to the authorisation in article 4.4 of the company's articles...
